Literature DB >> 3097458

Steroid and gonadotropin levels in women during the peri-menopausal years.

C Longcope, C Franz, C Morello, R Baker, C C Johnston.   

Abstract

We obtained blood samples from 88 women 45-58 yr old who were having cyclic menses every 1-2 mth (37 women, 133 samples) or were amenorrheic for greater than 3 mth (51 women, 310 samples). Samples were obtained at intervals of 3-4 mth and analyzed for estrogens, androgens and gonadotropins using radioimmunoassay techniques. There was a gradual decline in the concentrations of estrone (E1), estradiol (E2), estrone sulfate (E1SO4) and progesterone (P) as the time from the last menses increased. A relatively stable concentration was reached in 12 mth for E1, E2, and E1SO4 and in 2 mth for P. The concentrations of testosterone, dihydrotestosterone, androstenedione, dehydroepiandrosterone and dehydroepiandrosterone sulfate remained relatively constant as the time from the last menses increased. There was no apparent difference in the mean values of any of these hormones for any time interval from the last menses. The concentrations of both luteinizing hormone (LH) and follicle stimulating (FSH) were noted to increase initially but they appeared to become stable after 12 mth for FSH and after only 6 mth for LH. Using only the measurements made on the initial blood samples obtained in all patients, we found significant correlations between FSH concentrations and the concentrations of E1, E2 and E1SO4 for women who were less than 3 mth from a menses as well as those whose last menses had occurred 3 or more mth previously. The correlations were generally not significant for LH in either groups of women.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3097458     DOI: 10.1016/0378-5122(86)90025-3

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  32 in total

1.  Age, time since menopause, and body parameters as determinants of female spinal bone mass: a mathematical model.

Authors:  C Trevisan; S Ortolani; M L Bianchi; M P Caraceni; F M Ulivieri; G Gandolini; E E Polli
Journal:  Calcif Tissue Int       Date:  1991-07       Impact factor: 4.333

2.  Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell Line.

Authors:  Shaletha Holmes; Meharvan Singh; Chang Su; Rebecca L Cunningham
Journal:  Endocrinology       Date:  2016-05-11       Impact factor: 4.736

3.  Progesterone and ovulation across stages of the transition to menopause.

Authors:  Kathleen A O'Connor; Rebecca Ferrell; Eleanor Brindle; Benjamin Trumble; Jane Shofer; Darryl J Holman; Maxine Weinstein
Journal:  Menopause       Date:  2009 Nov-Dec       Impact factor: 2.953

Review 4.  Sex hormones and stroke: Beyond estrogens.

Authors:  Farida Sohrabji; Andre Okoreeh; Aditya Panta
Journal:  Horm Behav       Date:  2018-11-20       Impact factor: 3.587

5.  Genetic influences on hippocampal volume differ as a function of testosterone level in middle-aged men.

Authors:  Matthew S Panizzon; Richard L Hauger; Lindon J Eaves; Chi-Hua Chen; Anders M Dale; Lisa T Eyler; Bruce Fischl; Christine Fennema-Notestine; Carol E Franz; Michael D Grant; Kristen C Jacobson; Amy J Jak; Michael J Lyons; Sally P Mendoza; Michael C Neale; Elizabeth Prom-Wormley; Larry J Seidman; Ming T Tsuang; Hong Xian; William S Kremen
Journal:  Neuroimage       Date:  2011-10-01       Impact factor: 6.556

Review 6.  Asthma is Different in Women.

Authors:  Joe G Zein; Serpil C Erzurum
Journal:  Curr Allergy Asthma Rep       Date:  2015-06       Impact factor: 4.806

7.  Relating smoking, obesity, insulin resistance, and ovarian biomarker changes to the final menstrual period.

Authors:  MaryFran R Sowers; Daniel McConnell; Matheos Yosef; Mary L Jannausch; Sioban D Harlow; John F Randolph
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

8.  The relation of body size to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States).

Authors:  J F Dorgan; M E Reichman; J T Judd; C Brown; C Longcope; A Schatzkin; D Albanes; W S Campbell; C Franz; L Kahle
Journal:  Cancer Causes Control       Date:  1995-01       Impact factor: 2.506

9.  The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men.

Authors:  Donald J Brambilla; Alvin M Matsumoto; Andre B Araujo; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2008-12-16       Impact factor: 5.958

10.  Higher testosterone levels are associated with increased high-density lipoprotein cholesterol in men with cardiovascular disease: results from the Massachusetts Male Aging Study.

Authors:  Stephanie T Page; Beth A Mohr; Carol L Link; Amy B O'Donnell; William J Bremner; John B McKinlay
Journal:  Asian J Androl       Date:  2007-12-20       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.